- Home
- FTV vs WST Comparison
FTV vs WST Comparison
Compare FTV & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTV
- WST
- Stock Information
- Founded
- FTV 2015
- WST 1923
- Country
- FTV United States
- WST United States
- Employees
- FTV N/A
- WST N/A
- Industry
- FTV Industrial Machinery/Components
- WST Medical/Dental Instruments
- Sector
- FTV Industrials
- WST Health Care
- Exchange
- FTV Nasdaq
- WST Nasdaq
- Market Cap
- FTV 26.3B
- WST 23.2B
- IPO Year
- FTV N/A
- WST N/A
- Fundamental
- Price
- FTV $78.95
- WST $322.65
- Analyst Decision
- FTV Buy
- WST Buy
- Analyst Count
- FTV 14
- WST 3
- Target Price
- FTV $87.82
- WST $460.33
- AVG Volume (30 Days)
- FTV 3.0M
- WST 566.5K
- Earning Date
- FTV 10-30-2024
- WST 10-24-2024
- Dividend Yield
- FTV 0.41%
- WST 0.26%
- EPS Growth
- FTV 7.50
- WST N/A
- EPS
- FTV 2.50
- WST 6.74
- Revenue
- FTV $6,195,200,000.00
- WST $2,876,400,000.00
- Revenue This Year
- FTV $4.13
- WST N/A
- Revenue Next Year
- FTV $4.43
- WST $6.22
- P/E Ratio
- FTV $31.44
- WST $47.87
- Revenue Growth
- FTV 3.06
- WST N/A
- 52 Week Low
- FTV $66.15
- WST $265.00
- 52 Week High
- FTV $87.10
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- FTV 62.70
- WST 53.77
- Support Level
- FTV $78.48
- WST $315.17
- Resistance Level
- FTV $79.80
- WST $326.58
- Average True Range (ATR)
- FTV 1.18
- WST 9.63
- MACD
- FTV 0.48
- WST -0.42
- Stochastic Oscillator
- FTV 80.94
- WST 48.35
About FTV Fortive Corporation
Fortive is a diversified industrial technology firm with a broad portfolio of mission-critical products and services that include field solutions, product realization, health, and sensing technologies. The company serves a wide range of end markets, including manufacturing, utilities, medical, and electronics. Fortive generated roughly $6.1 billion in revenue in 2023.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.